Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

BioNTech

01.21.21

New Data Back Ability of Pfizer, BioNTech’s COVID-19 Vaccine to Foil UK Strain

Source: FirstWord

01.14.21

JPM: How did Pfizer Up its COVID-19 Vaccine Capacity? ‘Out of the Box Manufacturing,’ CEO Says

Source: FierceHealthcare

01.12.21

JPM: BioNTech Hikes COVID-19 Vaccine Output to 2B Doses in 2021—And Plans a Bigger Label, Too

Source: FierceHealthcare

01.04.21

UK Officials Defend Contingency Plan to Mix COVID-19 Vaccines in Rare Cases

Source: FirstWord

12.22.20

EU Authorizes First COVID-19 Vaccine With Pfizer, BioNTech’s Comirnaty

Source: FirstWord

12.17.20

Vaccine Rollout On Track, Expect 300M Doses Through March: Feds

Source: Medscape

12.11.20

FDA Panel Endorses Pfizer, BioNTech’s COVID-19 Vaccine

Source: FirstWord

12.10.20

Canada Authorises Pfizer, BioNTech’s COVID-19 Vaccine

Source: FirstWord

12.10.20

MHRA Advises Against Use of Pfizer, BioNTech’s COVID-19 Vaccine in Those With “Significant History” of Allergic Reactions

Source: FirstWord

12.09.20

No Red Flags in FDA Review of Pfizer, BioNTech’s COVID-19 Vaccine Candidate

Source: FirstWord

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.